Health Catalyst (HCAT) Stock Price
Health Catalyst Price
Health Catalyst (HCAT) Stock | ISIN US42225T1079 | WKN A2PH3J. The current Health Catalyst stock price is 1.74 USD (2026). Revenue is 289.67 M USD. Net income is 25.5 M USD. The P/E ratio is 4.77. Market capitalization is 121.62 M USD. Health Catalyst operates in the Health sector.
Revenue has compounded at 19.8% per year over the past 8 years to 311.14 M USD. Health Catalyst's net margin stands at -57.2%, up from -63.3% several years earlier.
Health Catalyst stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Health Catalyst over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Health Catalyst stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Health Catalyst's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Health Catalyst Price |
|---|
Health Catalyst Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Health Catalyst Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|
| 241 | 276 | 295 | 306 | 311 | 289 | 290 | 322 |
| 28.19 | 14.52 | 6.88 | 3.73 | 1.63 | -7.07 | 0.35 | 11.03 |
| 48.55 | 48.55 | 45.42 | 46.08 | 49.52 | 53.29 | 53.1 | 47.83 |
| 117 | 134 | 134 | 141 | 154 | 154 | 154 | 154 |
| -153 | -137 | -118 | -69 | -177 | 25 | 30 | 26 |
| 33.04 | -10.46 | -13.87 | -41.53 | 156.52 | -114.12 | 20 | -13.33 |
| 47.5 | 53.7 | 56.42 | 60.19 | 69.9 | 69.9 | 69.9 | 69.9 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Health Catalyst generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Health Catalyst retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Health Catalyst's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Health Catalyst has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Health Catalyst's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Health Catalyst stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Health Catalyst Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Health Catalyst business model & stock analysis
Health Catalyst SWOT Analysis
Strengths
Health Catalyst Inc. has a strong reputation in the healthcare industry, known for their data analytics solutions and expertise.
The company's software platform offers a comprehensive range of tools and features, providing advanced data-driven insights to healthcare organizations.
Health Catalyst Inc. has a talented and experienced team of data scientists and healthcare professionals, enabling them to develop innovative solutions tailored to meet the specific needs of their clients.
Weaknesses
One weakness of Health Catalyst Inc. is their relatively limited market presence compared to some larger competitors in the industry.
The company may face challenges in terms of scalability, as their solutions require significant infrastructure and resources to implement and maintain.
Health Catalyst Inc. may also struggle to keep up with the rapidly evolving technological landscape and changing healthcare regulations, which could impact the effectiveness of their solutions.
Opportunities
The increasing demand for data-driven healthcare solutions presents a significant opportunity for Health Catalyst Inc. to expand their market share and reach.
The company can leverage their expertise in data analytics to develop new products and services that cater to emerging healthcare trends and challenges.
Health Catalyst Inc. can also explore strategic partnerships and collaborations with other healthcare organizations to further enhance their offerings and broaden their customer base.
Threats
One of the major threats faced by Health Catalyst Inc. is the intense competition in the healthcare data analytics market, with numerous well-established players vying for market dominance.
Changes in healthcare policies and regulations can also pose a threat, as organizations may need to adapt or modify their software solutions to remain compliant.
Additionally, cyber threats and data breaches pose a significant risk to the company and its clients, requiring strong security measures and continuous monitoring.
Health Catalyst Segments
Health Catalyst Revenue by Segment (1/4)
3 Years
5 Years
Max
Details
Health Catalyst Revenue by Segment (2/4)
3 Years
5 Years
Max
Details
Health Catalyst Revenue by Segment (3/4)
3 Years
5 Years
Max
Details
Health Catalyst Revenue by Segment (4/4)
3 Years
5 Years
Max
Details
Health Catalyst Eulerpool Fair Value
Health Catalyst historical P/E ratio, EBIT multiple, and P/S ratio
Health Catalyst annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Health Catalyst shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Health Catalyst Earnings Estimates
Health Catalyst Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/12/2026 | 0.02USD | 70.55 MUSD | 2026 Q1 |
| 5/11/2026 | 0.02USD | 70.55 MUSD | 2026 Q1 |
| 5/5/2026 | 0.02USD | 70.55 MUSD | 2026 Q1 |
| 3/12/2026 | 0.09USD | 75.46 MUSD | 2025 Q4 |
| 3/3/2026 | 0.09USD | 75.46 MUSD | 2025 Q4 |
| 2/24/2026 | 0.09USD | 75.46 MUSD | 2025 Q4 |
| 8/7/2025 | 0.03USD | 82.22 MUSD | 2025 Q2 |
| 11/12/2024 | 0.1USD | 77.76 MUSD | 2024 Q3 |
| 5/7/2024 | 0USD | 81.9 MUSD | 2024 Q1 |
| 2/26/2024 | -0USD | 74.83 MUSD | 2023 Q4 |
EESG©
Eulerpool ESG Scorecard© for the Health Catalyst stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Health Catalyst shareholder structure
| % | Name |
|---|---|
18.47162% | |
6.49181% | |
6.14756% | |
6.10612% | |
5.72571% | |
5.57639% | |
3.93441% | |
2.74092% | |
2.38708% | |
2.34853% |
Health Catalyst Executives and Management Board
Mr. Benjamin Landry
(43)General Counsel, Corporate Secretary
Ms. Linda Llewelyn
(58)Chief People Officer
Mr. Jason Alger
(41)Chief Financial Officer
Mr. John Kane
(72)Director
Ms. Julie Larson-Green
(63)Independent Director
Health Catalyst Supply Chain
Frequently asked questions about Health Catalyst
The business model of Health Catalyst Inc is focused on providing data and analytics solutions to healthcare organizations. The company aims to enable these organizations in improving patient outcomes, reducing costs, and enhancing operational efficiency by leveraging their vast amount of healthcare data. Health Catalyst offers a comprehensive suite of products and services, including a data platform, analytics applications, and expertise in areas such as quality measures, population health management, and care coordination. By utilizing advanced data analytics, Health Catalyst assists healthcare organizations in making informed decisions, identifying areas for improvement, and ultimately transforming the way healthcare is delivered.
Health Catalyst stock
Health Catalyst Peer Group
Health Catalyst Ticker
Health Catalyst FIGI
All fundamentals and in-depth analysis of Health Catalyst
Our stock analysis for Health Catalyst Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Catalyst Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.